2026 Attendee Profile
SCOPE X debuted in Boston as an intimate, executive-level forum for clinical research leaders working at the intersection of artificial intelligence (AI), data strategy, clinical operations, and technology. The 2026 event emphasized candid discussion, practical implementation, and meaningful collaboration across the clinical research ecosystem.
Who Came to SCOPE X?
The inaugural event brought together senior decision-makers and practitioners responsible for shaping how AI and advanced data strategies are adopted across clinical development. The audience included leaders from:
- Pharmaceutical and biotechnology companies
- Clinical operations, clinical development, and data science teams
- Clinical research sites, CROs, and service organizations
- AI, software, digital health, and clinical technology companies
- Academic, advisory, investment, and innovation organizations
Why They Came
Attendees came to move beyond broad discussions of AI potential and examine what it takes to apply these technologies responsibly and effectively in clinical research. The program and onsite conversations centered on:
- Practical AI implementation across clinical operations and development
- Agentic AI, workflow redesign, and human accountability
- AI-ready data foundations, integration, lineage, and interoperability
- Governance, trust, validation, ethics, and responsible adoption
- Clinical trial design, monitoring, patient recruitment, and decision support
- Real-world case studies, lessons learned, and measurable business value
SCOPE X 2026 Testimonials
Hear what attendees had to say about the inaugural SCOPE X experience, beginning with the official 2026 event recap.
“SCOPE X is exactly the kind of conference I was looking to attend and it delivered. The sessions were incredibly informative and I was able to talk to numerous clinical operations decision makers.”
— Director of Business Development, Ryght AI
“SCOPE X brought together people passionate about implementing AI in clinical trials. The sessions were informative, conversations valuable, and connections important.”
— EVP Strategy, Soglia
“As a new event, the topics and speakers were excellent and timely. The intimacy of the conference lent well to productive conversations.”
— EVP, SOGLIA
"An informative event with relevant attendees discussing all things AI in pharma. A smaller crowd meant more opportunities to meet people and get to know the attendees. Some very interesting roundtable discussion, and I would definitely attend again next year to build on these important topics.”
— VP Clinical Integrity, EQTY Lab
“SCOPE X was Data Science meets Clinical Operations meets Tech, all meeting earlier than they usually meet today to talk about collaborating.”
— Managing Partner, Dauntless eClinical Strategies
“I thought SCOPE X was excellent. Bold, in the face, zoning in on AI in clinical trials - a topic so important and relevant to the life sciences industry today.”
— Research VP, Life Sciences R&D Strategy and Technology, IDC
“Excellent synopsis of progress being made applying AI across clinical operations and development.”
— Founder, Pharmaseal International Limited
“Kristian Hammond's session was a phenomenal experience. It kept me engaged in a way that few presentations do.”
— Clinical Trials Research Manager, Illinois Bone & Joint Institute
What the 2026 Experience Demonstrated
The strongest feedback consistently pointed to the value of a focused, cross-functional environment. Attendees highlighted the relevance of the AI content, the opportunity to connect with decision-makers, the quality of the discussions, and the ability to explore implementation challenges with peers facing similar questions.
Looking Ahead to 2027
Building on the inaugural event, SCOPE X will continue to convene clinical research executives, data leaders, and AI innovators while preserving the intimate format that supports deeper conversations and productive connections. Join us May 17–18, 2027, in Boston.
Programs
